FCF YoY
+3.91%
OCF YoY
+4.23%
Capex YoY
+10.34%
FCF Conversion Δ
-0.3 pp
Free cash flow bridge for Gilead Sciences (GILD) — TTM through Q1 2026 vs TTM through Q1 2025
Δ Free cash flow: $385.00M
FCF bridge breakdown for Gilead Sciences (GILD) — TTM through Q1 2026 vs TTM through Q1 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Free Cash Flow | $9.84B | — |
| Operating Cash Flow | $439.00M | +114.0% |
| Capital Expenditure | −$54.00M | -14.0% |
| Free Cash Flow | $10.23B | — |
- Prior Free Cash Flow$9.84B
- Operating Cash Flow$439.00M
- Capital Expenditure−$54.00M
- Free Cash Flow$10.23B
Identity check: drivers reconcile to ΔNI within $0.00 ✓
Want to see how cash flow is built up?Cash Flow Waterfall
Frequently asked questions
Data & methodology
Gilead Sciences (GILD) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement